Skip to main content
Subscribe
  • Sign Up Free
  • Login
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Opinion
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Digital Health Transformation Summit
    • ESG: The Implementation Imperative Summit
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Hospital at Home
    • - Workplace of the Future
    • - Digital Health
    • - Future of Staffing
    • - Hospital of the Future (Fall)
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
  • Data Center
    • Data Center Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Opinion
September 21, 2019 01:00 AM

Lowering drug prices with bipartisan, market-based proposals

Sen. James Lankford
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    Sen. James Lankford

    Most Americans are affected in some way by rising prescription drug and healthcare prices. Whether you’re personally impacted or hear about the effects of rising costs on a family member or friend, you know things aren’t getting better.

    The Senate Finance Committee, on which I serve, started working this year on a series of hearings to better understand the complexity of drug pricing, especially in the Medicare Part D prescription drug program. We’ve heard from pharmaceutical experts, federal regulators and patients. I’ve been surprised at the bipartisan common ground we’ve been able to achieve toward solutions in lowering prescription drug costs.

    To lower prescription costs, we should start with how they’re priced. Many people are comfortable interacting with their doctor or pharmacist and have a general understanding of the insurance that covers some of the cost and the drug companies that develop and sell the drugs. But the other component to drug pricing is the pharmacy benefit manager working behind the scenes to negotiate prices and determine access to the federally approved drugs covered by insurance plans.

    Sen. James Lankford (R-Okla.)

    SERVING SINCE: 2015, still in his first full term. He served two years of his predecessor’s term.

    HEALTHCARE-RELATED COMMITTEES: Senate Finance Committee, Senate Appropriations Committee and Senate Indian Affairs Committee.

    Lankford also serves on the Alzheimer’s, Diabetes and Down Syndrome caucuses in the Senate.

    PBMs are not inherently bad. They were created to advocate for lower prices throughout the system. But the negotiations behind the scenes can sometimes leave patients paying higher prices or restricting access to the latest generic. For example, a patient may have taken a brand-name drug that now has an available generic. Once the generic is approved by the Food and Drug Administration and a doctor prescribes it, patients should reasonably expect to pay a lower price for the generic at the pharmacy. But sometimes patients discover the new generic costs the same as the brand-name drug. How does that happen?

    In Medicare Part D, there are typically five tiers of drug prices within the insurance market that dictate the formulary for the costs patients pay at the pharmacy. When a new drug comes to market, the drug manufacturer negotiates with the Part D plan through the PBM to get the new drug into circulation and gain market share. After a period of time, that drug can also be produced in generic form, which usually costs significantly less. However, if you’ve found yourself paying brand-name prices for a new generic, it’s probably because the drug company negotiated the drugs into the same tier. So the patient pays the same price at the counter, but the PBM gets a “rebate” from the branded-drug company for helping block the new competition. That’s not how it’s supposed to work.

    In an equally concerning development, PBMs, many of which own a massive network of retail pharmacies, have been merging with insurers. This has decreased competition and limited consumer choice and access to certain drugs. Currently, three PBMs control nearly 80% of market share and that’s growing. When companies vertically integrate in the manner in which PBMs, insurers and big-box retail pharmacies have, consumers lose.

    In April, Senate Finance Committee Chair Chuck Grassley (R-Iowa) and I introduced the bipartisan Prescription Pricing for the People Act, which requires the Federal Trade Commission to study recent PBM mergers that have created an anti-competitive environment in the drug industry. On July 25, I joined a bipartisan group of senators to introduce the Phair Relief Act, Transparency for Pharmacists Act and the Right Price for Medicare Act. I have heard from Oklahoma pharmacies that want to provide price transparency to patients, but they are limited in how they can respond by PBM fees, rules and cost issues. We can help fix this anti-competitive mess and improve financial certainty for pharmacies. These bipartisan bills are a step in the right direction.

    We can and should find ways to ensure drug companies have the resources they need to find the next lifesaving drug or treatment. We can and should ensure patients can afford those treatments without declaring bankruptcy. Market-based solutions for pricing coupled with regulatory solutions for transparency can help increase drug options for consumers at affordable prices.

    More commentaries from members of the 116th Congress on the state of healthcare

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    20160830_Mike_Pykosz_mm0146(1).jpg
    Q&A: Oak Street Health CEO on growth plans after CVS Health deal
    Rapid growth predicted for hospital-at-home market
    Rapid growth predicted for hospital-at-home market
    Most Popular
    1
    More healthcare organizations at risk of credit default, Moody's says
    2
    Centene fills out senior executive team with new president, COO
    3
    SCAN, CareOregon plan to merge into the HealthRight Group
    4
    Blue Cross Blue Shield of Michigan unveils big push that lets physicians take on risk, reap rewards
    5
    Bright Health weighs reverse stock split as delisting looms
    Sponsored Content
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Opinion
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Digital Health Transformation Summit
        • ESG: The Implementation Imperative Summit
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Hospital at Home
        • - Workplace of the Future
        • - Digital Health
        • - Future of Staffing
        • - Hospital of the Future (Fall)
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • Data Center
      • Data Center Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing